Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Neurosciences Institute Clinical Research
293
mi
from 43215
Elk Grove Village, IL
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Neurosciences Institute Clinical Research
293
mi
from 43215
Elk Grove Village, IL
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Ruan Neurology Clinic and Research Center
564
mi
from 43215
Des Moines, IA
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Ruan Neurology Clinic and Research Center
564
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
ActivMed Practices & Research
642
mi
from 43215
Methuen, MA
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
ActivMed Practices & Research
642
mi
from 43215
Methuen, MA
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Alzheimer's Disease Research Center
559
mi
from 43215
Rochester, MN
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Alzheimer's Disease Research Center
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Neurological Research Center - Hattiesburg Clinic
692
mi
from 43215
Hattiesburg, MS
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Neurological Research Center - Hattiesburg Clinic
692
mi
from 43215
Hattiesburg, MS
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Millennium Psychiatric Associates, LLC
406
mi
from 43215
Creve Coeur, MO
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Millennium Psychiatric Associates, LLC
406
mi
from 43215
Creve Coeur, MO
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Memory Enhancement Center of America, Inc.
473
mi
from 43215
Eatontown, NJ
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Memory Enhancement Center of America, Inc.
473
mi
from 43215
Eatontown, NJ
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
The Atlantic Neuroscience Institute
443
mi
from 43215
Springfield, NJ
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
The Atlantic Neuroscience Institute
443
mi
from 43215
Springfield, NJ
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Advanced Memory Research Institute of NJ PC
463
mi
from 43215
Toms River, NJ
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Advanced Memory Research Institute of NJ PC
463
mi
from 43215
Toms River, NJ
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Neurological Associates of Albany, P. C.
513
mi
from 43215
Albany, NY
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Neurological Associates of Albany, P. C.
513
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
SPRI
484
mi
from 43215
Brooklyn, NY
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
SPRI
484
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Columbia University Taub Institute
442
mi
from 43215
New York, NY
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Columbia University Taub Institute
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Research Foundation for Mental Hygiene, Inc.
482
mi
from 43215
Orangeburg, NY
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Research Foundation for Mental Hygiene, Inc.
482
mi
from 43215
Orangeburg, NY
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
UNC Department of Neurology, Physicians Office Building
278
mi
from 43215
Chapel Hill, NC
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
UNC Department of Neurology, Physicians Office Building
278
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of America, Inc
307
mi
from 43215
Winston-Salem, NC
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of America, Inc
307
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Neurobehavioral Clinical Research
102
mi
from 43215
Canton, OH
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Neurobehavioral Clinical Research
102
mi
from 43215
Canton, OH
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
University Hospitals Case Medical Center, Neurology Clinical Trials Unit
129
mi
from 43215
Cleveland, OH
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
University Hospitals Case Medical Center, Neurology Clinical Trials Unit
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Rivers Wellness and Research Institute
849
mi
from 43215
Oklahoma City, OK
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Rivers Wellness and Research Institute
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
The Clinical Trial Center, LLC
418
mi
from 43215
Jenkintown, PA
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
The Clinical Trial Center, LLC
418
mi
from 43215
Jenkintown, PA
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania, Department of Neurology
414
mi
from 43215
Philadelphia, PA
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania, Department of Neurology
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
RI Hospital
619
mi
from 43215
Providence, RI
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
RI Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Neurology Clinic, PC
497
mi
from 43215
Cordova, TN
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Neurology Clinic, PC
497
mi
from 43215
Cordova, TN
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc (CNS Healthcare)
503
mi
from 43215
Memphis, TN
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc (CNS Healthcare)
503
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Neurology
1065
mi
from 43215
Austin, TX
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Senior Adults Specialty Research
1065
mi
from 43215
Austin, TX
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Senior Adults Specialty Research
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Dallas, LP
905
mi
from 43215
Dallas, TX
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Dallas, LP
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Independent Psychiatric Consultants
341
mi
from 43215
Waukesha, WI
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Independent Psychiatric Consultants
341
mi
from 43215
Waukesha, WI
Click here to add this to my saved trials
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  12/31/1969
Division of Rehabilitation and Aged Care
9457
mi
from 43215
Hornsby,
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 12/31/1969
Division of Rehabilitation and Aged Care
9457
mi
from 43215
Hornsby,
Click here to add this to my saved trials
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Rush University
277
mi
from 43215
Chicago, IL
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Rush University
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Harvard School of Public Health
640
mi
from 43215
Boston, MA
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Harvard School of Public Health
640
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease
A Phase 1 Study to Evaluate the Safety and Efficacy of Transcranial Electromagnetic Treatment (TEMT) for the Treatment of Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Byrd Alzheimer's Institute, University of South Florida
830
mi
from 43215
Tampa, FL
Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease
A Phase 1 Study to Evaluate the Safety and Efficacy of Transcranial Electromagnetic Treatment (TEMT) for the Treatment of Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Byrd Alzheimer's Institute, University of South Florida
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Probable Alzheimer's Disease or Progressive Supranuclear Palsy Compared With Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Molecular Neuroimaging, LLC
537
mi
from 43215
New Haven, CT
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Probable Alzheimer's Disease or Progressive Supranuclear Palsy Compared With Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Molecular Neuroimaging, LLC
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Irvine Center for Clinical Research
1956
mi
from 43215
Irvine, CA
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Irvine Center for Clinical Research
1956
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Brain Matters Research
948
mi
from 43215
Delray Beach, FL
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Brain Matters Research
948
mi
from 43215
Delray Beach, FL
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research Center of Southwest Florida
922
mi
from 43215
Fort Myers, FL
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research Center of Southwest Florida
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Bioclinica Research
795
mi
from 43215
Orlando, FL
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Bioclinica Research
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Progressive Medical Research
758
mi
from 43215
Port Orange, FL
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Progressive Medical Research
758
mi
from 43215
Port Orange, FL
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Cotton-O'Neil Clinical Research Center
677
mi
from 43215
Topeka, KA
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center
677
mi
from 43215
Topeka, KA
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
619
mi
from 43215
Providence, RI
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated:  12/31/1969
Great Lakes Clinical Trials
278
mi
from 43215
Chicago, IL
Tau Screening Study in Subjects With Early Symptomatic AD
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
Status: Enrolling
Updated: 12/31/1969
Great Lakes Clinical Trials
278
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
The Shankle Clinic
1967
mi
from 43215
Newport Beach, CA
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
The Shankle Clinic
1967
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of California, Davis; Alzheimers Disease Center, Department of Neurology
2042
mi
from 43215
Sacramento, CA
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of California, Davis; Alzheimers Disease Center, Department of Neurology
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
UCSF Memory and Aging Center
2109
mi
from 43215
San Francisco, CA
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
UCSF Memory and Aging Center
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Neurological Research Inst
1983
mi
from 43215
Santa Monica, CA
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Neurological Research Inst
1983
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Associated Neurologists, PC - Danbury
510
mi
from 43215
Danbury, CT
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Associated Neurologists, PC - Danbury
510
mi
from 43215
Danbury, CT
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
537
mi
from 43215
New Haven, CT
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
746
mi
from 43215
Ocala, FL
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Click here to add this to my saved trials